{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:00:40Z","timestamp":1760061640759},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1984,3,1]],"date-time":"1984-03-01T00:00:00Z","timestamp":446947200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Wochenschr"],"published-print":{"date-parts":[[1984,3]]},"DOI":"10.1007\/bf01721048","type":"journal-article","created":{"date-parts":[[2005,6,12]],"date-time":"2005-06-12T10:47:22Z","timestamp":1118573242000},"page":"225-230","source":"Crossref","is-referenced-by-count":3,"title":["Die Acetylsalicyls\u00e4urewirkung auf Partialfunktionen menschlicher Thrombozyten wird in vivo durch Salicyls\u00e4ure nicht gehemmt"],"prefix":"10.1007","volume":"62","author":[{"given":"R.","family":"Simrock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Lischke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Missalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Schwidtal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. K.","family":"Breddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01721048_CR1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0161-4630(79)90025-9","volume":"3","author":"M Ali","year":"1979","unstructured":"Ali M, McDonald JWD (1979) Interference by sulfinpyrazone and salicylate of aspirin inhibition of platelet cyclooxygenase activity. Prostaglandins Med 3:327\u2013332","journal-title":"Prostaglandins Med"},{"key":"BF01721048_CR2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1055\/s-0038-1646719","volume":"39","author":"K D'Angelo","year":"1978","unstructured":"D'Angelo K, Villa S, Mysliwiec M, Donati MB, de Gaetano G (1978) Defective fibrinolytic and prostacyclin-like activity in human atheromatous plaques. Thromb Haemost 39:535","journal-title":"Thromb Haemost"},{"key":"BF01721048_CR3","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/jama.1980.03300330019023","volume":"243","author":"Aspirin Myocardial Infarction Study Research Group","year":"1980","unstructured":"Aspirin Myocardial Infarction Study Research Group (1980) A randomised controlled trial of aspirin in persons recovered from myocardial infarction. J Am Med Assoc 243:661\u2013669","journal-title":"J Am Med Assoc"},{"key":"BF01721048_CR4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF01007868","volume":"37","author":"E Bamberg","year":"1978","unstructured":"Bamberg E, Bauer O, Herrmann W, Kroemer H, Lippmann M, M\u00fcller Ch, Stegmann H, Breddin K (1978) Prim\u00e4rer Formwandel der Thrombozyten in vitro. Blut 37:327\u2013329","journal-title":"Blut"},{"key":"BF01721048_CR5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0049-3848(79)90243-3","volume":"14","author":"N Bender","year":"1979","unstructured":"Bender N, Kirchmaier C, Bartsch B, Lindenborn D, Breddin K (1979) Stimulation of blood platelets by extracts of subcutaneous tissue. Thromb Res 14:341\u2013351","journal-title":"Thromb Res"},{"key":"BF01721048_CR6","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0140-6736(81)91371-4","volume":"II","author":"B Brantmark","year":"1981","unstructured":"Brantmark B, Hedner U, Melander A, W\u00e5hlin-Boll E (1981) Salicylate inhibition of antiplatelet effect of aspirin. Lancet II:1349","journal-title":"Lancet"},{"key":"BF01721048_CR7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF00548398","volume":"22","author":"B Brantmark","year":"1982","unstructured":"Brantmark B, Wahlin-Boll E, Melander A (1982) Bioavailability of acetylsalicylic acid and salicylic acid from rapid and slow-release formulations and in combination with dipyridamole. Eur J Clin Pharmacol 22:309\u2013314","journal-title":"Eur J Clin Pharmacol"},{"key":"BF01721048_CR8","first-page":"90","volume-title":"Fibrinstabilisierender Faktor, Struktur des Blutgerinnsels, Krebs und Gerinnung","author":"K Breddin","year":"1968","unstructured":"Breddin K (1968) Wirkung von Pharmaka auf die Pl\u00e4ttchenfunktion. In: Deutsch F, Fischer M, Lechner K (Hrsg) Fibrinstabilisierender Faktor, Struktur des Blutgerinnsels, Krebs und Gerinnung. Schattauer, Stuttgart, S 90\u201391"},{"key":"BF01721048_CR9","first-page":"325","volume":"9","author":"K Breddin","year":"1980","unstructured":"Breddin K, Loew D, Lechner K, \u00dcberla K, Walter E (1980a) Secondary prevention of myocardial infarction. A comparison of acetylsalicylic acid, placebo and phenprocoumon. Hemostasis 9:325\u2013344","journal-title":"Hemostasis"},{"key":"BF01721048_CR10","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0049-3848(80)90034-1","volume":"19","author":"K Breddin","year":"1980","unstructured":"Breddin K, Ziemen M, Bauer O, Herrmann W, Schaudinn L, Schlosserer U, Winterhagen A, Krzywanek H-J (1980b) Time and temperature dependent changes of ADP- and collageninduced and spontaneous aggregation. Thromb Res 19:621\u2013628","journal-title":"Thromb Res"},{"key":"BF01721048_CR11","first-page":"9","volume-title":"Prophylaxe ven\u00f6ser, peripherer, kardialer und zerebraler Gef\u00e4\u00dfkrankheiten mit Acetylsalicyls\u00e4ure","author":"K Breddin","year":"1981","unstructured":"Breddin K (1981) Zum Wirkungsmechanismus und zur Dosierung thrombozytenfunktionshemmender Medikamente. In: Prophylaxe ven\u00f6ser, peripherer, kardialer und zerebraler Gef\u00e4\u00dfkrankheiten mit Acetylsalicyls\u00e4ure. Schattauer, Stuttgart New York, pp 9\u201322"},{"issue":"Suppl. III","key":"BF01721048_CR12","first-page":"108","volume":"62","author":"MR Buchanan","year":"1980","unstructured":"Buchanan MR, Hirsh J (1980) The inhibitory effect of aspirin on platelet function independent of acetylation of cyclooxygenase. Circulation 62 (Suppl. III):108","journal-title":"Circulation"},{"key":"BF01721048_CR13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1056\/NEJM197807132990201","volume":"299","author":"Canadian Cooperative Study Group","year":"1978","unstructured":"Canadian Cooperative Study Group (1978) A randomised trial of aspirin and sulfinpyrazone in threatened stroke. New Engl J Med 299:53\u201359","journal-title":"New Engl J Med"},{"key":"BF01721048_CR14","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1055\/s-0038-1650191","volume":"45","author":"C Castellarneu de","year":"1981","unstructured":"de Castellarneu C, Cerletti C, Dejana E, Galetti F, Latini R, Livio M, de Gaetano G (1981) Salicylate-aspirin interaction and thrombosis prevention trials. Thromb Haemost 45:294","journal-title":"Thromb Haemost"},{"key":"BF01721048_CR15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM198207083070201","volume":"307","author":"JH Chesebro","year":"1982","unstructured":"Chesebro JH, Clements IP, Foster V, Elvebeck LR, Smith HC, Bardsley WT, Frye RL, Holmes DR, Vlietstra RF, Pluth JR, Wallace RB, Puga FJ, Orszulak TA, Piehler JM, Schaff HV, Danielson GK (1982) A platelet-inhibitory-drug trial in coronary-artery bypass operations. New Engl J Med 307:73\u201378","journal-title":"New Engl J Med"},{"key":"BF01721048_CR16","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1172\/JCI110336","volume":"68","author":"E Dejana","year":"1981","unstructured":"Dejana E, Cerletti C, de Castellarnau C, Livio M, Galetti F, Latini R, de Gaetano G (1981) Salicylate-aspirin interaction in the rat. Evidence that salicylate accumulation during aspirin administration may protect vascular prostacyclin from aspirin-induced inhibition. J Clin Invest 68:1108\u20131112","journal-title":"J Clin Invest"},{"key":"BF01721048_CR17","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/bmj.1.5905.436","volume":"II","author":"PC Elwood","year":"1974","unstructured":"Elwood PC, Cochrane AL, Burr MC, Sweetnam PM, Williams G, Welsby E, Hughes SJ, Renton R (1974) A randomised controlled trial of acetylsalicylic acid in the secondary prevention of mortality from myocardial infarction. Br Med J II:436\u2013443","journal-title":"Br Med J"},{"key":"BF01721048_CR18","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0140-6736(79)92808-3","volume":"II","author":"PC Elwood","year":"1979","unstructured":"Elwood PC, Sweetnam PM (1979) Aspirin and secondary mortality after myocardial infarction. Lancet II:1313\u20131315","journal-title":"Lancet"},{"key":"BF01721048_CR19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1161\/01.STR.8.3.301","volume":"8","author":"WS Fields","year":"1977","unstructured":"Fields WS, Lemak NA, Frankowski RF, Hardy RJ (1977) Controlled trial of aspirin in cerbral ischemia. Stroke 8:301\u2013305","journal-title":"Stroke"},{"key":"BF01721048_CR20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0140-6736(74)91525-6","volume":"II","author":"M Hamberg","year":"1974","unstructured":"Hamberg M, Svensson J, Samuelsson B (1974) Mechanism of the anti-aggregating effect of aspirin on human platelets. Lancet II:223\u2013224","journal-title":"Lancet"},{"key":"BF01721048_CR21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0049-3848(79)90271-8","volume":"16","author":"C Kirchmaier","year":"1979","unstructured":"Kirchmaier C, Bender N, Wilhelm B, Sayegh AA, Breddin K (1979) A hemostasis activating factor (HAF) in subcutaneous tissue extracts: effects on morphological platelet changes. Thromb Res 16:81\u201391","journal-title":"Thromb Res"},{"key":"BF01721048_CR22","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/jps.2600540703","volume":"54","author":"G Levy","year":"1965","unstructured":"Levy G (1965) Pharmacokinetics of salicylate elimination in man. J Pharm Sci 54:959\u2013967","journal-title":"J Pharm Sci"},{"key":"BF01721048_CR23","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1056\/NEJM198308183090703","volume":"309","author":"HD Lewis","year":"1983","unstructured":"Lewis HD, Davis JW, Archibald DG, Steinke WF, Smitherman TC, Doherty JE, Schnaper HW, LeWinter MM, Linares E, Pouget JM, Sabharwal SC, Chesler E, DeMots H (1983) Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. New Engl J Med 309:396\u2013403","journal-title":"New Engl J Med"},{"key":"BF01721048_CR24","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0140-6736(79)92334-1","volume":"II","author":"G Masotti","year":"1979","unstructured":"Masotti G, Galanti G, Poggesi I, Abbata R, Neri Serneri GG (1979) Differential inhibition of prostacyclin production and platelet aggregation. Lancet II:1213\u20131216","journal-title":"Lancet"},{"key":"BF01721048_CR25","unstructured":"Meng K, Tierexperimentelle Untersuchungen zur antithrombotischen Wirkung von Acetylsalicyls\u00e4ure. Ther Ber 47:67\u201369"},{"key":"BF01721048_CR26","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0006-2952(80)90401-3","volume":"29","author":"J Merino","year":"1980","unstructured":"Merino J, Livio M, Rajtar G, de Gaetano G (1980) Salicylate reverses in vitro aspirin inhibition of rat platelet and vascular prostaglandin generation. Biochem Pharmacol 29:1093\u20131096","journal-title":"Biochem Pharmacol"},{"key":"BF01721048_CR27","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0025-7125(16)31495-X","volume":"65","author":"SA Metz","year":"1981","unstructured":"Metz SA (1981) Anti-inflammatory agents as inhibitors of prostaglandin Synthesis in man. Med Clin N A 65:713\u2013757","journal-title":"Med Clin N A"},{"key":"BF01721048_CR28","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0140-6736(68)92228-9","volume":"I","author":"JR O'Brien","year":"1968","unstructured":"O'Brien JR (1968) Effects of salicylates on human platelets. Lancet I:779\u2013783","journal-title":"Lancet"},{"key":"BF01721048_CR29","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0140-6736(78)92661-2","volume":"II","author":"J O'Grady","year":"1978","unstructured":"O'Grady J, Moncada J (1978) Aspirin: a paradoxical effect on bleeding time. Lancet II:780","journal-title":"Lancet"},{"key":"BF01721048_CR30","first-page":"371","volume":"I","author":"FI Pareti","year":"1980","unstructured":"Pareti FI, D'Angelo A, Manucci PM, Smith JB (1980) Platelet and the vessel wall: how much aspirin? Lancet I:371\u2013372","journal-title":"Lancet"},{"key":"BF01721048_CR31","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1161\/01.CIR.62.3.449","volume":"62","author":"Persantin-Aspirin Study Research Group","year":"1980","unstructured":"Persantin-Aspirin Study Research Group (1980) Persantin and aspirin in coronary heart disease. Circulation 62:449\u2013461","journal-title":"Circulation"},{"key":"BF01721048_CR32","unstructured":"Pietsch U, Lippmann M, Scharrer I, Breddin K (1977) Neue Befunde zur Wirkung der Acetylsalicyls\u00e4ure: Die Hemmung auf den Formwandel der Thrombozyten und ihre Bedeutung f\u00fcr die Dosierung als Antithrombotikum. In: Alexander K, Cachovan M (Hrsg) Diabetische Angiopathien Baden-Baden, S 348\u2013351"},{"key":"BF01721048_CR33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00000441-196609000-00003","volume":"252","author":"AJ Quick","year":"1966","unstructured":"Quick AJ, (1966) Salicylates and bleeding: the aspirin tolerance test. Amer J Med Sci 252:265\u2013269","journal-title":"Amer J Med Sci"},{"key":"BF01721048_CR34","unstructured":"Rosenthal D, Breddin HK (1983\/84) Volumenmessungen von Blutzellen mit Hilfe der hydrodynamischen Fokussierung. (in Vorbereitung)"},{"key":"BF01721048_CR35","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1073\/pnas.72.8.3073","volume":"72","author":"GJ Roth","year":"1975","unstructured":"Roth GJ, Stanford N, Majerus PW (1975) Acetylation of prostaglandin synthetase by aspirin. Proc Nat Acad Sci USA 72:3073\u20133076","journal-title":"Proc Nat Acad Sci USA"},{"key":"BF01721048_CR36","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/jps.2600610312","volume":"61","author":"M Rowland","year":"1972","unstructured":"Rowland M, Riegelman S, Harris PA, Sholkoff SD (1972) Absorption kinetics of aspirin in man following oral administration of an aques solution. J Pharm Sci 61:379\u2013385","journal-title":"J Pharm Sci"},{"key":"BF01721048_CR37","unstructured":"Sherwood J, Kreutner W (1978) Salicylic acid prevents the inhibition of platelet prostaglandin synthetase by indomethacinlike antiinflammatory agents. Fed Proc 37:605A"},{"key":"BF01721048_CR38","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF01497779","volume":"61","author":"R Simrock","year":"1983","unstructured":"Simrock R, Spahn H, Breddin HK, Mutschler E (1983) Reversible Hemmung der Thrombozytenstimulation durch Acetylsalicyls\u00e4ure und ihre Bedeutung f\u00fcr die antithrombotische Therapie. Klin Wochenschr 61:297\u2013302","journal-title":"Klin Wochenschr"},{"key":"BF01721048_CR39","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1055\/s-0038-1666920","volume":"42","author":"H Sinzinger","year":"1979","unstructured":"Sinzinger H, Silberbauer K, Feigl W, Wagner O, Winter M, Auerswald W (1979) Prostacyclin activity is diminished in different types of morphologically controlled human atherosclerotic lesions. Thromb Haemost 42:803\u2013804","journal-title":"Thromb Haemost"},{"key":"BF01721048_CR40","first-page":"235","volume":"231","author":"JB Smith","year":"1971","unstructured":"Smith JB, Willis AL (1971) Aspirin selectively inhibits prostaglandin production in human platelets. Nature 231:235\u2013237","journal-title":"Nature"},{"key":"BF01721048_CR41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.2042-7158.1978.tb13171.x","volume":"30","author":"B Vargaftig","year":"1978","unstructured":"Vargaftig B (1978a) Salicylic acid fails to inhibit generation of thromboxane A2 activity in platelets after in vivo administration to the rat. J Pharm Pharmacol 30:101\u2013104","journal-title":"J Pharm Pharmacol"},{"key":"BF01721048_CR42","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0014-2999(78)90355-2","volume":"50","author":"B Vargaftig","year":"1978","unstructured":"Vargaftig B (1978b) The inhibition of cyclooxygenase of rabbit platelets by aspirin is prevented by salicylic acid and by phenanthrolines. Eur J Pharmacol 50:231\u2013241","journal-title":"Eur J Pharmacol"},{"key":"BF01721048_CR43","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1172\/JCI105903","volume":"47","author":"HJ Weiss","year":"1968","unstructured":"Weiss HJ, Aledort LM, Kochwa S (1968) The effect of salicylates on hemostatic properties of platelets in man. J Clin Invest 47:2169\u20132180","journal-title":"J Clin Invest"},{"key":"BF01721048_CR44","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJM198304073081402","volume":"308","author":"BB Weksler","year":"1983","unstructured":"Weksler BB, Pett SB, Alonso D, Richter RC, Stelzer P, Subramanian V, Tack-Goldman K, Gay WA (1983) Differential inhibition by aspirin of vascular und platelet prostaglandin synthesis in atherosclerotic patients. New Engl J Med 308:800\u2013805","journal-title":"New Engl J Med"},{"key":"BF01721048_CR45","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0049-3848(79)90228-7","volume":"16","author":"R Zimmermann","year":"1979","unstructured":"Zimmermann R, Thiessen RM, M\u00f6rl H, Weckesser G (1979) The paradoxical thrombogenic effect of aspirin in experimental thrombosis. Thromb Res 16:843\u2013846","journal-title":"Thromb Res"},{"key":"BF01721048_CR46","first-page":"66","volume":"76","author":"MB Zucker","year":"1970","unstructured":"Zucker MB, Peterson J (1970) Effect of acetylsalicylic acid and other non-steroidal antiinflammatory agents and dipyridamole on human blood platelets. J Lab Clin Med 76:66\u201375","journal-title":"J Lab Clin Med"}],"container-title":["Klinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01721048.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01721048\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01721048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T09:22:14Z","timestamp":1557307334000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01721048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,3]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1984,3]]}},"alternative-id":["BF01721048"],"URL":"https:\/\/doi.org\/10.1007\/bf01721048","relation":{},"ISSN":["0023-2173","1432-1440"],"issn-type":[{"value":"0023-2173","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984,3]]}}}